These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4285224)

  • 21. Tolrivizin in the treatment of trophic ulcers in leprosy.
    Ranade SN; Joshi PB; Deshpande SM; Kotnis MG; Apte AN
    Indian J Dermatol; 1965 Oct; 11(1):17-20. PubMed ID: 5867877
    [No Abstract]   [Full Text] [Related]  

  • 22. Unsatisfactory results with thalidomide as a specific treatment for leprosy.
    Sheskin J; Sagher F; Dorfman M; Schrader-Beielstein HW
    Isr J Med Sci; 1968; 4(4):901-4. PubMed ID: 5710961
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of leprosy using sulfamethoxypyrimidine].
    Mattos O; Rabelo Neto AV
    Rev Bras Med; 1970 Jun; 27(6):328-30. PubMed ID: 5488613
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sulfonamides and leprous neuritis].
    Carayon A; Languillon J; Daney P
    Bull Soc Med Afr Noire Lang Fr; 1965; 10(4):560-2. PubMed ID: 5865751
    [No Abstract]   [Full Text] [Related]  

  • 25. [1st results of the treatment of leprosy with rifampicin in New Caledonia].
    Chanalet G; Guyon J; Beaute J; Parc F; Boutier F
    Med Trop (Mars); 1972; 32(2):203-15. PubMed ID: 5082187
    [No Abstract]   [Full Text] [Related]  

  • 26. The effectiveness of corticosteroids in the treatment of long-term nerve function impairment.
    Croft R; Richardus JH; Smith WC
    Lepr Rev; 1996 Dec; 67(4):342-3. PubMed ID: 9033206
    [No Abstract]   [Full Text] [Related]  

  • 27. The condition of the peripheral nerve in leprosy under various forms of treatment. Conduction velocity studies in long-term follow-up.
    Magora A; Sheskin J; Sagher F; Gonen B
    Int J Lepr Other Mycobact Dis; 1971; 39(2):639-52. PubMed ID: 4948099
    [No Abstract]   [Full Text] [Related]  

  • 28. The condition of the peripheral nerve in leprosy under various forms of treatment. Conduction velocity studies in long-term follow-up.
    Magora A; Sheskin J; Sagher F; Gonen B
    Int J Lepr Other Mycobact Dis; 1970; 38(2):149-63. PubMed ID: 5529246
    [No Abstract]   [Full Text] [Related]  

  • 29. [Thalidomide in the treatment of leprosy reactions. 3 years of experience in Mexico].
    Latapí F; Saúl A; Gómez-Vidal M
    Gac Med Mex; 1969 Oct; 99(10):917-31. PubMed ID: 5363611
    [No Abstract]   [Full Text] [Related]  

  • 30. [The treatment of leprosy and recurrent nodular lepromatous hypodermitis with griseofulvin].
    Silva E
    Dermatol Int; 1968; 7(1):37-42. PubMed ID: 5741762
    [No Abstract]   [Full Text] [Related]  

  • 31. Streptomycin combined with sulfones in the treatment of relapsed lepromatous leprosy.
    Hastings RC; Trautman JR
    Int J Lepr Other Mycobact Dis; 1968; 36(1):45-51. PubMed ID: 5689649
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 33. Dapsone haemolysis in leprosy. A preliminary report.
    Menezes S; Rege VL; Sehgal VN
    Lepr India; 1981 Jan; 53(1):63-9. PubMed ID: 7218764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Supidimide, a non-teratogenic thalidomide analog for the treatment of leprosy reaction?].
    Sheskin J; Mückter H; Frankus E
    Hautarzt; 1983 Apr; 34(4):168-70. PubMed ID: 6853166
    [No Abstract]   [Full Text] [Related]  

  • 35. Multi-drug treatment for reactions in leprosy.
    Razack EM; Zahra A
    Lepr India; 1981 Apr; 53(2):204-12. PubMed ID: 7253572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dimorphous leprosy].
    Esca SA; Zelger J
    Hautarzt; 1984 Jun; 35(6):298-302. PubMed ID: 6469634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Initial results of prospective controlled treatment trials in leprosy].
    Pattyn SR
    Verh K Acad Geneeskd Belg; 1984; 46(3):207-19. PubMed ID: 6391013
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapy of leprosy with rifampicin.
    Wilkinson FF; Gago J; Santabaya E
    Int J Lepr Other Mycobact Dis; 1972; 40(1):53-7. PubMed ID: 4672996
    [No Abstract]   [Full Text] [Related]  

  • 40. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report.
    Devadason C
    Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.